Avycaz was developed by Forest, another company which the M&A hungry Actavis acquired in 2014. Avycaz contains two drugs: ceftazidime, a previously approved cephalosporin antibacterial ...

In Actavis Labs. FL, Inc. v. U.S.  (“Actavis”), a recent precedential decision, the Federal Circuit answered an important ...

branded drugs. Today, Teva’s generics division is a $14-15bn pro forma revenue company, with nearly 16,500 employees operating in 80 markets. It utilises the most advanced research and development ...